Minocycline in Multiple Sclerosis - Compelling Results but Too Early to Tell

Zongqi Xia1, Robert M Friedlander1

  • 1From the Program in Translational Neurology and Neuroinflammation, Pittsburgh Institute of Neurodegenerative Diseases (Z.X.), and the Institute of Multiple Sclerosis Care and Research, Department of Neurology (Z.X.), and the Neuroapoptosis Laboratory, Department of Neurosurgery (R.M.F.), University of Pittsburgh School of Medicine and University of Pittsburgh Medical Center - all in Pittsburgh.

Abstract

No abstract available in PubMed .